GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis.
Document Type
Journal Article
Publication Date
11-11-2016
Student Program
MD
Journal
Circulation Research
Volume
119
Issue
11
Inclusive Pages
1242-1253
DOI
10.1161/CIRCRESAHA.116.309637
Keywords
Adult; Biomarkers; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Female; Humans; Inflammation; Inflammation Mediators; Male; Middle Aged; Psoriasis; Risk Factors
APA Citation
Joshi, A., Lerman, J., Aberra, T., Afshar, M., Teague, H., Rodante, J., Krishnamoorthy, P., Ng, Q., Aridi, T., Salahuddin, T., Natarajan, B., Lockshin, B., Ahlman, M., Chen, M., Rader, D., Reilly, M., Remaley, A., Bluemke, D., Playford, M., Gelfand, J., & Mehta, N. (2016). GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis.. Circulation Research, 119 (11). http://dx.doi.org/10.1161/CIRCRESAHA.116.309637
Peer Reviewed
1
